HepatoChem
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$100k | Seed | ||
$330k | Debt | ||
Total Funding | CAD136k |
Related Content
Recent News about HepatoChem
EditHepatoChem specializes in providing innovative photochemistry solutions that enable rapid and cost-effective synthesis of drug metabolites. The company serves pharmaceutical and biotechnology firms, focusing on enhancing the drug development pipeline by offering advanced chemical synthesis tools. Operating in the chemical and pharmaceutical markets, HepatoChem's business model revolves around offering specialized photochemistry services and tools, such as their PhotoRedox Exploration Tool, which allows clients to explore various reaction possibilities. The company generates revenue through service contracts and tool subscriptions, catering to clients who seek efficient and economical methods for drug metabolite synthesis. By leveraging cutting-edge photochemistry techniques, HepatoChem aims to reduce the time and cost associated with traditional metabolite synthesis methods, thereby accelerating drug discovery and development processes.
Keywords: photochemistry, drug metabolites, pharmaceutical, biotechnology, synthesis, PhotoRedox, cost-effective, rapid, chemical synthesis, innovation.